Weixler Benjamin, Lobbes Leonard A, Scheiner Luis, Lauscher Johannes C, Staubli Sebastian M, Zuber Markus, Raptis Dimitri A
Department of General and Visceral Surgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Hindenburgdamm 30, 12203 Berlin, Germany.
Department of Hepato-Pancreatico-Biliary Surgery and Liver Transplantation, Royal Free Hospital, London NW3 2QG, UK.
Life (Basel). 2023 May 31;13(6):1290. doi: 10.3390/life13061290.
Successful R0 resection is crucial for the survival of patients with primary liver cancer (PLC) or liver metastases. Up to date, surgical resection lacks a sensitive, real-time intraoperative imaging modality to determine R0 resection. Real-time intraoperative visualization with near-infrared light fluorescence (NIRF) using indocyanine green (ICG) may have the potential to meet this demand. This study evaluates the value of ICG visualization in PLC and liver metastases surgery regarding R0 resection rates.
Patients with PLC or liver metastases were included in this prospective cohort study. ICG 10 mg was administered intravenously 24 h before surgery. Real-time intraoperative NIRF visualization was created with the Spectrum fluorescence imaging camera system. First, all liver segments were inspected with the fluorescence imaging system and intraoperative ultrasound for identification of the known tumor, as well as additional lesions, and were compared to preoperative MRI images. PLC, liver metastases, and additional lesions were then resected according to oncological principles. In all resected specimens, the resection margins were analyzed with the fluorescence imaging system for ICG-positive spots immediately after resection. Histology of additional detected lesions, as well as ICG fluorescence compared to histological resection margins, were assessed.
Of the 66 included patients, median age was 65.5 years (IQR 58.7-73.9), 27 (40.9%) were female, and 18 (27.3%) were operated on laparoscopically. Additional ICG-positive lesions were detected in 23 (35.4%) patients, of which 9 (29%) were malignant. In patients with no fluorescent signal at the resection margin, R0 rate was 93.9%, R1 rate was 6.1%, and R2 rate was 0% compared to an ICG-positive resection margin with an R0 rate of 64.3%, R1 rate of 21.4%, and R2 rate of 14.3% ( = 0.005). One- and two-year overall survival rates were 95.2% and 88.4%, respectively.
The presented study provides significant evidence that ICG NIRF guidance helps to identify R0 resection intraoperatively. This offers true potential to verify radical resection and improve patient outcomes. Furthermore, implementation of NIRF-guided imaging in liver tumor surgery allows us to detect a considerable amount of additional malignant lesions.
成功的R0切除对于原发性肝癌(PLC)或肝转移瘤患者的生存至关重要。迄今为止,手术切除缺乏一种敏感的、实时的术中成像方式来确定R0切除。使用吲哚菁绿(ICG)的近红外光荧光(NIRF)实时术中可视化可能有潜力满足这一需求。本研究评估ICG可视化在PLC和肝转移瘤手术中对R0切除率的价值。
本前瞻性队列研究纳入了PLC或肝转移瘤患者。术前24小时静脉注射10毫克ICG。使用Spectrum荧光成像系统进行实时术中NIRF可视化。首先,用荧光成像系统和术中超声检查所有肝段,以识别已知肿瘤以及其他病变,并与术前MRI图像进行比较。然后根据肿瘤学原则切除PLC、肝转移瘤和其他病变。在所有切除的标本中,切除后立即用荧光成像系统分析切缘有无ICG阳性点。评估额外检测到的病变的组织学以及与组织学切缘相比的ICG荧光情况。
66例纳入患者中,中位年龄为65.岁(四分位间距58.7 - 73.9),27例(40.9%)为女性,18例(27.3%)接受了腹腔镜手术。23例(35.4%)患者检测到额外的ICG阳性病变,其中9例(29%)为恶性。切缘无荧光信号的患者中,R0切除率为93.9%,R1切除率为6.1%,R2切除率为0%;相比之下,切缘ICG阳性的患者中,R0切除率为64.3%,R1切除率为21.4%,R2切除率为14.3%(P = 0.005)。1年和2年总生存率分别为95.2%和88.4%。
本研究提供了重要证据,表明ICG NIRF引导有助于术中识别R0切除。这为验证根治性切除和改善患者预后提供了真正的潜力。此外,在肝肿瘤手术中实施NIRF引导成像使我们能够检测到大量额外的恶性病变。